Coree K. Thomas
CIK: 0002149248
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NVST
Envista Holdings Corp
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Thomas Coree K.
Thomas Coree K. (SEC CIK 0002149248) files insider reports with the SEC as CAO of Envista Holdings Corp (NVST).
Signal8 holds 1 ownership filing by Thomas Coree K., a Form 3, filed on Aug 13, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Thomas Coree K.'s filings is in BREA, CA.
Other insiders filing for Envista Holdings Corp (NVST)
- Keel Paul A, Chairman and CEO
- Acurio Veronica, President, Orthodontics
- Befidi Robert, President, Diagnostics
- Hammes Eric D., Chief Financial Officer
- Nilsson Stefan, President, Nobel Biocare
- Reis Mischa, SVP, Strategy & Bus. Dev.